Joint associations (HR, 95% CI) of habitual iron supplement use and hypertensive status (normotension or hypertension) as well as antihypertensive status of participants with hypertension (without medication or with medication) with chronic kidney disease incidence in the 1:4 propensity score-matched...
Ferric citrateis an iron supplement your doctor may give you if you’re on dialysis for chronic kidney disease (CKD) and your body is having trouble controlling the phosphorus levels in your blood. People with CKD who aren’t on dialysis might also get ferric citrate if they have iron defic...
non-dialysisdependent chronic kidney disease It is not known if Monoferric is safe and effective for use in children less than 18 years old. What are the side effects of Monoferric? Monoferric may cause serious side effects, including: Allergic(hypersensitivity) reactions.Serious life-threatening ...
Iron deficiency is common among patients with advanced kidney disease, particularly those requiring hemodialysis. Intravenous iron is a convenient treatment to supplement iron and is widely used among hemodialysis patients. Its efficacy is well established that, with treatment, hemoglobin levels rise and ...
3 CKD, chronic kidney disease; ESA, erythropoietin-stimulating agent; IV, intravenous; NDD, non–dialysis-dependent. In individuals with CKD who are eligible for kidney transplant, it is vital that they are prevented from receiving transfusions or becoming transfusion-dependent because of severely ...
Iron overload is a pathological condition characterized by the abnormal accumulation of iron within the body, which may result from excessive iron intake, disorders of iron metabolism, or specific disease states. This condition can lead to significant he
Ferumoxytol is an intravenous iron preparation for treatment of the anemia of chronic kidney disease (CKD). It is a carbohydrate-coated, superparamagnetic ... MH Schwenk - 《Pharmacotherapy the Journal of Human Pharmacology & Drug Therapy》 被引量: 67发表: 2010年 Diagnosing and treating anemia an...
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney international (2012), pp. 1-335 Supplement 2 View in ScopusGoogle Scholar Michael et al., 2002 B. Michael, D.W. Coyne, S. Fishbane, V. Folkert, R. Lynn, A.R. Nissenson, R. Agarwal, J.W. Eschbach, S....
Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease [Sicherheitsaspekte parenteraler Eisentherapien bei Pat... Iron deficiency often occurs in patients with chro Potthoff,A S.,Münch,... - 《Dmw Deutsche Medizinische Wochenschrift》 被引量: 0发表: 2013...
Iron deficiencies are the most common nonenteric syndromes observed in patients with inflammatory bowel disease, but little is known about their impacts on immune tolerance. Here we show that homeostasis of regulatory T cells in the intestine was depende